120 related articles for article (PubMed ID: 37992987)
21. Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma.
Wang S; Ma X; Ying Y; Sun J; Yang Z; Li J; Jin K; Wang X; Xie B; Zheng X; Liu B; Xie L
Cancer Cell Int; 2021 Jul; 21(1):341. PubMed ID: 34217271
[TBL] [Abstract][Full Text] [Related]
22. Interleukin 20 receptor subunit beta (IL20RB) predicts poor prognosis and regulates immune cell infiltration in clear cell renal cell carcinoma.
Zhang H; Liu Y; Wang B; Wang C
BMC Genom Data; 2022 Jul; 23(1):58. PubMed ID: 35883015
[TBL] [Abstract][Full Text] [Related]
23. Elevated expression of LIF predicts a poor prognosis and promotes cell migration and invasion of clear cell renal cell carcinoma.
Zhong W; Liu H; Li F; Lin Y; Ye Y; Xu L; Li S; Chen H; Li C; Lin Y; Zhuang W; Lin Y; Wang Q
Front Oncol; 2022; 12():934128. PubMed ID: 35992780
[TBL] [Abstract][Full Text] [Related]
24. FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity.
Dong K; Chen W; Pan X; Wang H; Sun Y; Qian C; Chen W; Wang C; Yang F; Cui X
BMC Cancer; 2022 Feb; 22(1):140. PubMed ID: 35120484
[TBL] [Abstract][Full Text] [Related]
25. Systematic Construction and Validation of a Novel Macrophage Differentiation-Associated Prognostic Model for Clear Cell Renal Cell Carcinoma.
Liu C; Zhang X; Hu C; Liang X; Cao X; Wang D
Front Genet; 2022; 13():877656. PubMed ID: 35774505
[No Abstract] [Full Text] [Related]
26. TPD52L2 as a potential prognostic and immunotherapy biomarker in clear cell renal cell carcinoma.
Wang H; Liu Z; Du Y; Cheng X; Gao S; Gao Y; Shang P
Front Oncol; 2023; 13():1210910. PubMed ID: 38074636
[TBL] [Abstract][Full Text] [Related]
27. Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma.
Zhong M; Wang X; Zhu E; Gong L; Fei L; Zhao L; Wu K; Tang C; Zhang L; Wang Z; Zheng Z
Front Genet; 2022; 13():905051. PubMed ID: 35846134
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma.
Huang S; Hou Y; Hu M; Hu J; Liu X
BMC Cancer; 2022 Sep; 22(1):995. PubMed ID: 36123627
[TBL] [Abstract][Full Text] [Related]
29. Upregulated X-C motif chemokine ligand 2 (XCL2) is associated with poor prognosis and increased immune infiltration in clear cell renal cell carcinoma.
Cao Q; Liu D; Chen Z; Wang M; Wu M; Zeng G
Cell Signal; 2023 Feb; 102():110556. PubMed ID: 36503163
[TBL] [Abstract][Full Text] [Related]
30. Identification and Validation of the Prognostic Panel in Clear Cell Renal Cell Carcinoma Based on Resting Mast Cells for Prediction of Distant Metastasis and Immunotherapy Response.
Su Y; Zhang T; Lu J; Qian L; Fei Y; Zhang L; Fan S; Zhou J; Tang J; Chen H; Liang C
Cells; 2023 Jan; 12(1):. PubMed ID: 36611973
[TBL] [Abstract][Full Text] [Related]
31. Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma.
Fu L; Bao J; Li J; Li Q; Lin H; Zhou Y; Li J; Yan Y; Langston ME; Sun T; Guo S; Zhou X; Chen Y; Liu Y; Zhao Y; Lu J; Huang Y; Chen W; Chung BI; Luo J
Front Immunol; 2022; 13():1021935. PubMed ID: 36248876
[TBL] [Abstract][Full Text] [Related]
32. Identification of an immunogenic cell death-related gene signature predicts survival and sensitivity to immunotherapy in clear cell renal carcinoma.
Zhou S; Lu Y; Chen Y; Gan W
Sci Rep; 2023 Mar; 13(1):4449. PubMed ID: 36932108
[TBL] [Abstract][Full Text] [Related]
33. Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database.
Xiao GF; Yan X; Chen Z; Zhang RJ; Liu TZ; Hu WL
Front Genet; 2020; 11():810. PubMed ID: 33014010
[TBL] [Abstract][Full Text] [Related]
34. Identification of candidate biomarker
Lv Q; Xiao W; Xiong Z; Shi J; Miao D; Meng X; Yuan H; Yang H; Zhang X
Front Biosci (Landmark Ed); 2021 Nov; 26(11):1176-1190. PubMed ID: 34856762
[No Abstract] [Full Text] [Related]
35. A novel gene signature related to oxidative stress predicts the prognosis in clear cell renal cell carcinoma.
Ma S; Ge Y; Xiong Z; Wang Y; Li L; Chao Z; Li B; Zhang J; Ma S; Xiao J; Liu B; Wang Z
PeerJ; 2023; 11():e14784. PubMed ID: 36785707
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive Analysis of m
Wu J; Hou C; Wang Y; Wang Z; Li P; Wang Z
Int J Genomics; 2021; 2021():3803724. PubMed ID: 34631874
[TBL] [Abstract][Full Text] [Related]
37. CTLA4 has a profound impact on the landscape of tumor-infiltrating lymphocytes with a high prognosis value in clear cell renal cell carcinoma (ccRCC).
Liu S; Wang F; Tan W; Zhang L; Dai F; Wang Y; Fan Y; Yuan M; Yang D; Zheng Y; Deng Z; Liu Y; Cheng Y
Cancer Cell Int; 2020; 20():519. PubMed ID: 33117084
[TBL] [Abstract][Full Text] [Related]
38. Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma.
Chen X; Tu J; Ma L; Huang Y; Yang C; Yuan X
Int J Gen Med; 2022; 15():3215-3235. PubMed ID: 35342303
[TBL] [Abstract][Full Text] [Related]
39. Identification and experimental validation of a tumor-infiltrating lymphocytes-related long noncoding RNA signature for prognosis of clear cell renal cell carcinoma.
Deng Y; Guo K; Tang Z; Feng Y; Cai S; Ye J; Xi Y; Li J; Liu R; Cai C; Tan Z; Zhang Y; Han Z; Zeng G; Zhong W
Front Immunol; 2022; 13():1046790. PubMed ID: 36505457
[TBL] [Abstract][Full Text] [Related]
40. Development of a TGF-β signaling-related genes signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma.
Wu X; Xie W; Gong B; Fu B; Chen W; Zhou L; Luo L
Front Oncol; 2023; 13():1124080. PubMed ID: 36776317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
